SCYX
NASDAQ
$4.23
Scynexis Inc (SCYX)
SCYNEXIS, Inc., a biotechnology company, offers therapies for the treatment of yeast infections in the United States. The company is headquartered in Jersey City, New Jersey.
Sector:
Healthcare
Strong Buy
Target: $33.55 (+693.14%)
Market Cap
$32M
Profit Margin
65.7%
Free Cash Flow Yield
-16.41%
Beta (5Y)
0.96
Price Chart
Valuation
Market Cap$32M
Forward P/E3.72
P/S2.13
P/B1.05
Profitability
Total Revenue (TTM)$20M
Gross Profit (TTM)$20M
EBITDA-$25M
Profit Margin65.7%
Operating Margin56.3%
EPS-$3.54
Financial Health
Free Cash Flow Yield-16.41%
Growth & Risk
EPS 5Y CAGR-31.46%
Revenue 5Y CAGR+11.04%
FCF 5Y CAGR-35.20%
Beta (5Y)0.96
Sharpe Ratio-0.40